Skip to Content
MilliporeSigma
All Photos(3)

Documents

159891

Sigma-Aldrich

3-Methoxybenzylamine

98%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
CH3OC6H4CH2NH2
CAS Number:
Molecular Weight:
137.18
Beilstein/REAXYS Number:
1447182
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

assay

98%

refractive index

n20/D 1.547 (lit.)

bp

140 °C/37 mmHg (lit.)

density

1.072 g/mL at 25 °C (lit.)

SMILES string

COc1cccc(CN)c1

InChI

1S/C8H11NO/c1-10-8-4-2-3-7(5-8)6-9/h2-5H,6,9H2,1H3

InChI key

GRRIMVWABNHKBX-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

3-Methoxybenzylamine was used in the preparation of 6-substituted purines.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible, corrosive hazardous materials

wgk_germany

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 7

1 of 7

4-Chlorobenzylamine 98%

Sigma-Aldrich

C27409

4-Chlorobenzylamine

Piperonylamine 97%

Sigma-Aldrich

P49503

Piperonylamine

3-Picolylamine ≥99%

Sigma-Aldrich

A65409

3-Picolylamine

Benzylamine ReagentPlus®, 99%

Sigma-Aldrich

185701

Benzylamine

Marek Zatloukal et al.
European journal of medicinal chemistry, 61, 61-72 (2012-07-10)
Several inhibitors of cyclin-dependent kinases (CDKs), including the 2,6,9-trisubstituted purine derivative roscovitine, are currently being evaluated in clinical trials as potential anticancer drugs. Here, we describe a new series of roscovitine derivatives that show increased potency in vitro. The series

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service